Trial Profile
Long-Term Extension Study of RO4917838 in Japanese Patients with Schizophrenia
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 10 Jun 2016
Price :
$35
*
At a glance
- Drugs Bitopertin (Primary)
- Indications Schizophrenia
- Focus Adverse reactions
- Sponsors Chugai Pharmaceutical
- 10 Jun 2016 New trial record